Zogenix Submits New Drug Application for FINTEPLA® (Fenfluramine) in Japan for the Treatment of…
EMERYVILLE, Calif., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Zogenix, a global biopharmaceutical company specializing in rare disease therapies, announced that it has submitted a New Drug Application (J-NDA) to the Japanese Ministry of Health,…